STAAR Surgical Company STAA
NASDAQ
| 10/02/2026 | 07/03/2026 | 04/03/2026 | 01/02/2026 | 09/26/2025 | |
|---|---|---|---|---|---|
| Revenue | 83.41M | 93.54M | 93.52M | 57.80M | 94.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 83.41M | 93.54M | 93.52M | 57.80M | 94.73M |
| Cost of Revenue | 24.28M | 23.81M | 24.66M | 14.06M | 16.86M |
| Gross Profit | 59.14M | 69.73M | 68.86M | 43.74M | 77.88M |
| SG&A Expenses | 43.13M | 49.60M | 41.45M | 45.40M | 44.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 77.87M | 83.35M | 76.04M | 68.71M | 70.23M |
| Operating Income | 5.54M | 10.18M | 17.48M | -10.91M | 24.50M |
| Income Before Tax | 6.98M | 11.02M | 8.22M | -20.65M | 18.79M |
| Income Tax Expenses | 1.41M | 2.97M | 3.01M | -2.34M | 9.91M |
| Earnings from Continuing Operations | 5.58M | 8.06M | 5.21M | -18.31M | 8.88M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.58M | 8.06M | 5.21M | -18.31M | 8.88M |
| EBIT | 5.54M | 10.18M | 17.48M | -10.91M | 24.50M |
| EBITDA | 7.98M | 12.57M | 19.59M | -8.90M | 26.50M |
| EPS Basic | 0.11 | 0.16 | 0.10 | -0.37 | 0.18 |
| Normalized Basic EPS | 0.09 | 0.14 | 0.22 | -0.11 | 0.31 |
| EPS Diluted | 0.11 | 0.16 | 0.10 | -0.37 | 0.18 |
| Normalized Diluted EPS | 0.08 | 0.13 | 0.22 | -0.11 | 0.31 |
| Average Basic Shares Outstanding | 50.54M | 50.32M | 49.91M | 49.76M | 49.63M |
| Average Diluted Shares Outstanding | 51.45M | 51.50M | 50.90M | 49.76M | 50.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |